Inogen (Nasdaq:INGN) shares are down today — a day after releasing Q2 results that beat the consensus forecast. The Goleta, California–based respiratory care company posted losses of $3.4 million, or 15¢ per share, on sales of $103.4 million for the three months ended June 30, 2022, for a bottom-line slide into the red on sales […]
Respiratory
ResMed acquires Mementor and its digital health app for insomnia
ResMed (NYSE: RMD, ASX: RMD) announced today that it has acquired Mementor (Leipzig) and its digital insomnia therapy in a bid to strengthen its overall sleep portfolio in Germany. The deal closed yesterday. ResMed did not disclose financial terms. The maker of CPAPs and other respiratory therapy devices was one of the first medical device […]
Tactile Systems revenue beats Wall Street estimates in Q2
Tactile Systems (NSDQ: TCMD) this week posted second-quarter results that included Street-beasting revenues. The Minneapolis-based maker of at-home therapies for underserved, chronic conditions reported losses of $4.6 million, or -23¢ per share, on sales of $59.6 million for the three months ended June 30, for a sales growth of 16.81% compared with Q2 2021. Adjusted […]
Inspire Medical appoints new independent board directors
Inspire Medical Systems (NYSE:INSP) announced today that it appointed Cynthia Burks and Dr. Charisse Sparks as board directors. The appointment of Burks and Sparks as independent directors to the board of the minimally invasive sleep apnea treatment developer was made effective on July 28, 2022. Burks previously served as chief human resources officer for Genentech […]
Philips stock down on news of supply chain woes, consent decree talks with DOJ
Philips (NYSE:PHG) shares took a hit today on second-quarter earnings that were adversely affected by supply chain headwinds. CEO Frans van Houten also broke the news during today’s earnings call that the U.S. Department of Justice, acting on behalf of FDA, provided a proposed consent decree on July 18 following inspection of the Dutch medtech […]
Merit Medical launches smallest, shortest configuration of pulmonary balloon dilator
Merit Medical Systems (Nasdaq:MMSI) announced today that it launched the smallest and shortest configuration of its Elation portfolio. South Jordan, Utah-based Merit designed its new Elation pulmonary balloon to allow physicians to accurately match balloon diameter and length to specific small airways in the lungs, offering treatment options to more patients through an expanded range […]
Stimdia Medical raises $16M for neurostim to get people off ventilators
Stimdia Medical announced recently that it completed the initial closing of a $16 million tranche of its Series B financing round. Solas Bioventures led the financing round, while new strategic partners and existing investors Draper Triangle Ventures also contributed funding. Minneapolis-based Stimdia designed its pdSTIM system to offer a tool for addressing high-risk patients, including […]
Inspira unveils Liby ECMO system for treating heart, lung failure
Inspira Technologies (Nasdaq:IINN) today introduced the Liby system for extracorporeal membrane oxygenation (ECMO) treatment. Ra’anana, Israel-based Inspira expects its Liby system, currently under development, to be submitted to the FDA for regulatory approval during the first half of 2023. ECMO technology pumps, oxygenates and removes carbon dioxide from blood for patients whose lungs can’t provide […]
Hologic launches new assays for COVID-19, flu, RSV in Europe
Hologic (Nasdaq:HOLX) announced today that it now offers its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Novodiag test in Europe. Marlborough, Massachusetts-based Hologic designed its Panther Fusion and Novodiag (RESP-4 molecular diagnostic) tests detect and differentiate four of the most prevalent respiratory viruses that can present with similar clinical symptoms in SARS-CoV-2, influenza A and B […]
New data backs Aerin’s RhinAer for treating chronic rhinitis
Aerin Medical today announced the publication of positive results from a 12-month study of its RhinAer platform. Results from Sunnyvale, California–based Aerin’s Rhintrac randomized, sham-controlled clinical trial, published in the International Forum of Allergy & Rhinology (IFAR), demonstrated that chronic rhinitis symptoms continued to improve through 12 months after treatment with RhinAer. Findings build on […]
Lyra Therapeutics appoints new chief medical officer
Lyra Therapeutics (Nasdaq:LYRA) announced today that it appointed Dr. Richard Nieman as its new chief medical officer (CMO). Nieman’s appointment as CMO of Lyra, which develops the XTreo — a platform for enabling precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — will be made […]